MAM
Amidst COVID-19 Pandemic Maharishi Ayurveda Launches AyurDefence-AV
One of the pioneering Science-based Ayurvedic company — Maharishi Ayurveda today announced the expansion of its Ayurvedic Healthcare portfolio with the launch of its 100% Ayurvedic product AyurDefence-AV amidst the COVID-19 pandemic. This is completely a herbal product made up of the combination of 19 herbs, possessing functional attributes of turning out to be the armour against viral infection & seasonal flu. It has the property to enhance the body’s innate intelligence, which works synergistically for more vitality, inner strength, stability and balance to strengthen immunity.
Announcing the launch, Maharishi Ayurveda Chairman, Mr Anand Shrivastava, said, “Given the COVID-19 pandemic situation, we are passing through the age of infection wherein protecting ourselves from this is utmost important for survival. In such a situation, recognising the non-availability of medicines for curing viral infections, and realising the fact that firstly not all the population gets infected, whilst most of those who do get infected also recoup, accepting a few who pass-away, we have launched this product, which is the need of the hour.
“The launch of this product is a step forward in the direction of launching products based on the age-old knowledge of Ayurveda in modern-day convenient formats. We always try to introduce safe, effective and affordable health care products for all by marrying the traditional knowledge of Ayurveda with modern-day science & technology. The synergistic effect of the herbs in AyurDefence-AV helps the body strengthen its immunity”, added Mr Anand Shrivastava.
Upon asking specific questions whether AyurDefence-AV will be effective for covid-19 virus also? Mr Shrivastava further added that “Covid-19 is also a virus and like other viruses present in the atmosphere there is no medicine to kill this virus as well. Our body's immunity is the only remedy to give appropriate response to covid-19 in the same way as it deals with any other virus. Since AyurDefence-AV strengthens the body's immunity and defence mechanism, it will be definitely helpful to our physiology in getting rid of the virus very soon. If AyurDefence-AV tables are taken immediately upon seeing the initial symptoms like sore throat, headache, stiffness, etc. it will support the physiology in preventing further spread of the virus and one can be free from infection faster, without much damage”.
Viral infections or flu indicated by symptoms like runny nose, sore or strep throat, body ache, stiffness, headache, shortness of breath result in drowsiness, weakness, sluggishness and much more depending upon the type of virus or other pathogens involved. The symptoms differ and sometimes depending upon the comorbid conditions may become serious or even fatal.
“We have been passing through the time of viral infection. Usually, we get infected through bacterial infections as well as the viral infection. However, for bacterial infections, some antibiotic medicines are available, but for other pathogens, specifically in viral infections, antibiotic medicines do not work and neither is any medicine available for treating such viruses. Nowadays, people who are worried about the side effects of the medicines, this product – AyurDefence-AV will work wonders for them”, said, Dr Saurabh Sharma, Medical Superintendent, Maharishi Ayurveda Hospital.
AyurDefence-AV is made up of 19 herbs, which help the body to combat the viral infection and flu-like symptoms e.g. fever, runny nose, difficulty in breathing, cough, headache, stiffness. The synergistic effect of the herbs in it also helps the body to strengthen its immunity.
As AyurDefence-AV is a combination of well-known, highly effective herbs like — Tulsi, Kali Mirch (Piper Nigrum), Ginger, Long pepper, Cumin, Licorice, Bilva ,Giloy, Sonth, Pippali, Mulethi and Lahsun. And these herbs have the characteristics to strengthen the body’s guard against any external health threats including bacterial and viral infection. This product made up of herbs also works as Bronchodilator, Immuno-modulator, Antimicrobial, Anti-allergic, Antipyretic, Analgesic, Anti-viral, Anti-inflammatory and Antitussive.
It promotes balance in Dosha, Agni and Dhatu, eliminating Ama (improperly-digested impurities) that can block microcirculatory channels. This way Ama is reduced and does not reach the other parts of the body, especially the respiratory system, hence prevents creation of weak sites. This also helps decrease microbial load, balance mucus production and in building immunity. It also promotes Ojas, which further promotes the balance, provides vigour to the body and strengthens immunity.
Brands
KPMG names Gary Wingrove as global chairman and CEO from October
Record Gmada bids signal rising demand as Rs 1,000 crore bet reshapes Tricity skyline
MUMBAI: KPMG has chosen continuity with a forward tilt. The firm has announced that Gary Wingrove will take over as global chairman and CEO of KPMG International, beginning a four year term from 1 October 2026. Currently serving as global chief operating officer, Wingrove steps into the top role after being nominated by the global board and elected by the global council.
A KPMG veteran with over 25 years at the firm, Wingrove has been closely involved in shaping its recent trajectory. As global COO, he has helped drive the firm’s Collective Strategy, focusing on operational integration, global investments and the steady expansion of the KPMG Delivery Network. He has also been at the forefront of KPMG’s digital push, including the rollout of AI enabled solutions across its global operations.
Before his global role, Wingrove served as CEO of KPMG Australia for nearly a decade, where he led a period of strong growth, almost doubling revenue, profitability and headcount while steering a cultural reset.
He succeeds Bill Thomas, who has led KPMG since 2017 and will work alongside Wingrove over the next six months to ensure a smooth transition.
Thomas leaves behind a firm that looks markedly different from when he took charge. Under his leadership, KPMG’s global revenues have risen by 55 per cent, and its workforce has expanded to more than 276,000 people. He also unified the network of member firms under the Collective Strategy, aligning priorities and strengthening governance.
His tenure saw heavy investment in technology and partnerships, with alliances spanning Microsoft, Google Cloud, SAP, Oracle and ServiceNow. These collaborations, along with platforms like KPMG Clara, have helped the firm scale its AI-led offerings and sharpen its competitive edge.
Beyond growth, Thomas also pushed improvements in audit quality and sustainability. Initiatives such as a multiyear global sustainability strategy and the Our Impact Plan have aimed to embed long term thinking into the firm’s operations and client services.
For Wingrove, the brief is clear but evolving. He has signalled a focus on agility, deep expertise and technology driven solutions as clients navigate an increasingly complex business landscape. He also emphasised KPMG’s identity as a people first organisation, supported by technology and unified through its global network.
The timing of the leadership change comes as KPMG continues to grow, reporting a 5.1 per cent rise in global revenue in FY25, with gains across tax and legal, audit and advisory services. Growth was recorded across all regions, despite a challenging macro environment.
As Wingrove prepares to take charge, the firm appears set on a familiar path with a sharper digital edge. Same playbook, perhaps, but with a renewed focus on speed, scale and smarter solutions.
